Mongolia vs Nepal: Average cost of multi drug-resistant tuberculosis treatment
Mongolia
1,500 constant 2022 US$
in 2024
Nepal
1,526 constant 2022 US$
in 2024
Mongolia rank
34th
Nepal rank
33rd
Average cost of multi drug-resistant tuberculosis treatment over time
- Mongolia
- Nepal
How they compare
Nepal currently reports 1,526 constant 2022 US$ against 1,500 constant 2022 US$ in Mongolia, a difference of 26 constant 2022 US$.
The two have swapped places 3 times across 7 shared years of data; in 2018 it was Mongolia ahead.
Mongolia ranks 34th and Nepal ranks 33rd of 92 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,610 constant 2022 US$ | 1,165 constant 2022 US$ | 1,445 constant 2022 US$ | Mongolia |
| 2020s | 1,455 constant 2022 US$ | 1,226 constant 2022 US$ | 228.4 constant 2022 US$ | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Mongolia or Nepal?
- Nepal, at 1,526 constant 2022 US$ against 1,500 constant 2022 US$ in Mongolia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Mongolia and Nepal?
- 26 constant 2022 US$, with Nepal ahead.
- How many years of comparable data are there for Mongolia and Nepal?
- 7 years are reported by both, from 2018 to 2024.
- How do Mongolia and Nepal rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Mongolia ranks 34th and Nepal ranks 33rd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.